IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-129

  1. 395 Posts.
    lightbulb Created with Sketch. 48
    Panic selling now. Completely irrational. There's a P3 study underway and there's still a market for a drug that we know works. In Q3, they could very well announce that, yes, the market is not as badly affected as we thought and all is on track. We'll request an amendment to ethics and to the EMA, and timelines/cash are the same...
    Last edited by ejjwj: 29/06/23
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.